Erratum to ‘Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertility-sparing approach: an analysis of the ETERNITY project’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101643] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001665), (10.1016/j.ijgc.2025.101643))

In the original published version of this article, the following errors were introduced during the copyediting process by the Suppliers. The text originally published “CT tomography and transvaginal ultrasonography were not routinely performed.” Has been corrected to “CT scan and transvaginal ultrasonography were not routinely performed” The text originally published “This was a retrospective analysis of data included in the early-stage cervical cancer scheduled for the fertility-sparing (ETERNITY) project.” Has been corrected to “This is a retrospective analysis of data included in the Early-sTage cERvical caNcer scheduled for fertilItY-sparing (ETERNITY) project.” The text originally published “The median (range) of patients was 37 (24-41) years.” Has been corrected to “The median (range) of patients age was 37 (24-41) years.” The text originally published “The Clavien-Dindo severity system was used to classify severe complications, and the Martin criteria were used to improve the quality of reporting.13 of reported data on 90-day severe morbidity (starting from the day of nodal evaluation).” Has been corrected to “The Clavien-Dindo severity system was used to classify severe complications, and the Martin criteria were used to improve the quality of reporting.13 We reported data about 90-day severe morbidity (starting from the day of nodal evaluation).” The text originally published “The advantages (efficacy) and disadvantages (risk of ovarian failure) of immune checkpoint inhibitors (ICI) adoption of immune checkpoint inhibitors in this setting must be carefully considered.” Has been corrected to “The advantages (efficacy) and disadvantages (risk of ovarian failure) of adopting immune checkpoint inhibitors (ICI) in this setting must be carefully considered.” These errors bear no reflection on the article or its authors. The publisher apologizes to the authors and the readers for this unfortunate error.